Question 1

How many shares of CTOR does UBS Group AG own?

Accepted Answer

As of 2026-Q2, UBS Group AG holds 334,619 shares of CTOR (CITIUS ONCOLOGY INC).

Question 2

What is UBS Group AG's CTOR position worth?

Accepted Answer

As of 2026-Q2, UBS Group AG's CTOR position is worth $217,502.

Question 3

Is UBS Group AG buying or selling CTOR?

Accepted Answer

In 2026-Q2, UBS Group AG increased their CTOR position (+808.3% change in shares).

Question 4

When did UBS Group AG first buy CTOR?

Accepted Answer

Based on available 13F filings, UBS Group AG first reported a position in CTOR in 2024-Q3. They have held the position across 8 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	334,619	+808.3%	$217,502	0.0%	$0.65	25
2026-Q1	Increased	36,840	+71.6%	$22,840	0.0%	$1.06	19
2025-Q4	Increased	21,464	+389x	$21,464	0.0%	$1.05	21
2025-Q3	Decreased	55	-99.6%	$112	0.0%	$2.03	0
2025-Q2	Decreased	15,423	-69.0%	$67,090	0.0%	$4.50	0
2025-Q1	Increased	49,745	+100.5%	$46,263	0.0%	$0.67	22
2024-Q4	Increased	24,805	+1419.9%	$28,526	0.0%	$1.12	21
2024-Q3	New	1,632	-	$2,268	0.0%	$1.40	18

CTOR8 quarters

CTOR
8 quarters